Skip to main content
HR 6505 115th Congress House

Medicare Negotiation and Competitive Licensing Act of 2018

Official title: To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program.

Introduced: July 25, 2018 Introduced by: Doggett, Lloyd Democratic · Texas See on congress.gov
Health Competition and antitrustDrug safety, medical device, and laboratory regulationHealth care costs and insuranceInflation and prices
More subjectsShow fewer subjects
Licensing and registrationsManufacturingMedicarePrescription drugsProduct safety and qualityPublic contracts and procurement
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 3, 2018
Referred to the Subcommittee on Health.
Jul 27, 2018
Referred to the Subcommittee on Health.
Jul 25, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 25, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action August 3, 2018

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Medicare Negotiation and Competitive Licensing Act of 2018

This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. (Current law prohibits the CMS from doing so.)

The CMS must take certain factors into account during negotiations, including the clinical- and cost-effectiveness of the drug, the financial burden on patients, and unmet patient needs. If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under Medicare, notwithstanding existing government-granted exclusivities.

Additionally, for one year after a drug is provided under a competitive license, such drug is also subject to specified price limitations; if the drug is not offered at such prices, the drug is subject to additional licensing that furthers its sale under any federal program (e.g., Medicaid).

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 104
All 104 Democratic 58
D
Castor, Kathy
Florida · Dec 20, 2018
Sires, Albio
· Dec 20, 2018
 D
Gallego, Ruben
Arizona · Dec 19, 2018
Wild, Susan
· Dec 19, 2018
 D
Lynch, Stephen F.
Massachusetts · Oct 5, 2018
 D
Huffman, Jared
California · Oct 2, 2018
ROYBAL-ALLARD, LUCILLE
· Oct 2, 2018
CLAY, WM.
· Sep 28, 2018
Kildee, Daniel
· Sep 28, 2018
Lipinski, Daniel
· Sep 28, 2018
Loebsack, David
· Sep 28, 2018
Richmond, Cedric
· Sep 28, 2018
 D
Suozzi, Thomas R.
New York · Sep 28, 2018
 D
Thompson, Mike
California · Sep 28, 2018
 D
Matsui, Doris O.
California · Sep 27, 2018
 D
Watson Coleman, Bonnie
New Jersey · Sep 27, 2018
 D
Schiff, Adam B.
California · Sep 26, 2018
 D
Courtney, Joe
Connecticut · Sep 12, 2018
 D
Lofgren, Zoe
California · Sep 12, 2018
Yarmuth, John
· Aug 10, 2018
RUSH, BOBBY
· Aug 7, 2018
DOYLE, MIKE
· Aug 3, 2018
 D
Dingell, Debbie
Michigan · Jul 27, 2018
Maloney, Sean
· Jul 26, 2018
 D
Torres, Norma J.
California · Jul 26, 2018
 D
Adams, Alma S.
North Carolina · Jul 25, 2018
 D
Barragán, Nanette Diaz
California · Jul 25, 2018
Bass, Karen
· Jul 25, 2018
 D
Beatty, Joyce
Ohio · Jul 25, 2018
Blumenauer, Earl
· Jul 25, 2018
 D
Bonamici, Suzanne
Oregon · Jul 25, 2018
Cartwright, Matt
· Jul 25, 2018
 D
Castro, Joaquin
Texas · Jul 25, 2018
 D
Chu, Judy
California · Jul 25, 2018
Cicilline, David
· Jul 25, 2018
 D
Clarke, Yvette D.
New York · Jul 25, 2018
 D
Cleaver, Emanuel
Missouri · Jul 25, 2018
 D
Cohen, Steve
Tennessee · Jul 25, 2018
Crist, Charlie
· Jul 25, 2018
CUMMINGS, ELIJAH
· Jul 25, 2018
 D
Davis, Danny K.
Illinois · Jul 25, 2018
DEFAZIO, PETER
· Jul 25, 2018
 D
DeLauro, Rosa L.
Connecticut · Jul 25, 2018
 D
DeSaulnier, Mark
California · Jul 25, 2018
Ellison, Keith
· Jul 25, 2018
 D
Espaillat, Adriano
New York · Jul 25, 2018
 D
Evans, Dwight
Pennsylvania · Jul 25, 2018
 D
Frankel, Lois
Florida · Jul 25, 2018
 D
Garamendi, John
California · Jul 25, 2018
 D
Gonzalez, Vicente
Texas · Jul 25, 2018
Page 1 of 3 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-6505/
MLA
"H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-6505/.
Bluebook (legal)
H.R. 6505, 115th Cong. (2026), https://openamerica.io/bill/115-HR-6505/.
Markdown link
[H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018](https://openamerica.io/bill/115-HR-6505/)
Report a problem